Neoadjuvant Oncogene-Targeted Therapy in Early Stage Non-Small-Cell Lung Cancer as a Strategy to Improve Clinical Outcome and Identify Early Mechanisms of Resistance. [electronic resource]
- Clinical lung cancer 09 2016
- 466-469 p. digital
Publication Type: Journal Article
1938-0690
10.1016/j.cllc.2016.05.025 doi
Antineoplastic Agents--administration & dosage Carcinoma, Non-Small-Cell Lung--drug therapy Clinical Trials as Topic--methods Disease Progression Drug Resistance, Neoplasm Humans Lung Neoplasms--drug therapy Molecular Targeted Therapy Neoadjuvant Therapy Neoplasm Staging Proto-Oncogene Mas